SCHEMBL29469876

SCHEMBL29469876

NS(=O)(=O)c1cc(O)cc2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.62
CA1 P00915 4/20 0.58
CA9 Q16790 4/20 0.58
CA2 P00918 3/20 0.58
LDHA P00338 1/20 0.52
MCL1 Q07820 2/20 0.50
CYP2C9 P11712 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TRPM4 Q8TD43 1/20 0.48
CDK2 P24941 1/20 0.47
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
MPI P34949 1/20 0.46
KMT2A Q03164 1/20 0.46
CA12 O43570 3/20 0.43
ATIC P31939 1/20 0.43
CDC25B P30305 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10817165 1.00 NQO2 (0.62) NQO2CA1CA9CA2LDHA
SCHEMBL669147 0.85 NQO2 (0.55) NQO2CA1CA9CA2CYP2C9
SCHEMBL29965723 0.85 NQO2 (0.55) NQO2CA1CA9CA2MCL1
SCHEMBL547642 0.85 NQO2 (0.55) NQO2CA1CA9CA2MCL1
Ammonia Solution, Strong SCHEMBL7523204 0.83 NQO2 (0.53) NQO2CA1CA9CA2CYP2C9
SCHEMBL7859087 0.83 NQO2 (0.53) NQO2CA1CA9CA2CYP2C9
Sulfuric Acid SCHEMBL10415586 0.81 NQO2 (0.80) NQO2CA1CA9CA2LDHA
SCHEMBL7859084 0.80 NQO2 (0.50) NQO2CA1CA9CA2MCL1
SCHEMBL4559508 0.79 CA1 (0.60) CA1CA9CA2LDHAMCL1
SCHEMBL1807638 0.79 CA2 (0.60) NQO2CA1CA9CA2LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed